# 1.1 Research Context — Veterinary Clinical Pathol - 2025 - Neal - Artificial Intelligence in Veterinary Clinical Pathology An Introduction and
> Source: `Sources/Veterinary Clinical Pathol - 2025 - Neal - Artificial Intelligence in Veterinary Clinical Pathology An Introduction and.docx` | Date: 2026-09-24 | Depth: standard
> Verdict (Task 2): HIGHLY USABLE
---
### Task 1 — Bibliographic Classification
- **Title**: Artificial Intelligence in Veterinary Clinical Pathology—An Introduction and Review
- **Authors**: Samuel V. Neal, Daniel G. Rudmann, Kara N. Corps
- **Year**: 2025
- **Recency**: PASS (2016–2026)
- **Outlet**: Veterinary Clinical Pathology, 54(Suppl. 2), S13–S29
- **DOI/URL**: https://doi.org/10.1111/vcp.70012
- **Setting**: Foreign (United States) + proof: “Department of Veterinary Biosciences, College of Veterinary Medicine, Ohio State University, Columbus, Ohio, USA”
- **Design**: Review (narrative review of AI concepts, data preparation, validation, veterinary applications, limitations, and oversight)
- **APA7**: Neal, S. V., Rudmann, D. G., & Corps, K. N. (2025). Artificial intelligence in veterinary clinical pathology—An introduction and review. *Veterinary Clinical Pathology, 54*(Suppl. 2), S13–S29. https://doi.org/10.1111/vcp.70012
- **Fit**: Supplies recent veterinary evidence that digital clinical data are not self-validating: incomplete records, imbalance, hallucination, model drift, and limited training coverage can create clinical-information risks.

### Task 2 — Verdict
- **Verdict**: HIGHLY USABLE (4 mechanisms, 2 slots)
- **Bullets (3–5)**:
  - Why this verdict + recency status: PASS (2025); the full 13,829-word review states four concrete data-quality and clinical-safety mechanisms across two allowed 1.1 slots.
  - Slots populated → Features 1–7 mapping: [Macro-Digital-Transformation] → Feature 2; [Micro-Clinical-Breaking-Points] → Feature 2.
  - Missing slots / metrics this source cannot cover: [Meso-Rural-Provincial-Constraints], [Manual-Ledger-Vulnerabilities], and [Statutory-Imperatives-RA10173-RA9268] are not directly supported; no Philippine clinic baseline or paper-ledger rate is reported.
  - Panel use (what attack this citation deflects): counters the claim that digitized veterinary data automatically yield reliable AI insight by showing that incomplete, biased, unsupported, or temporally shifted inputs can degrade clinical information.
  - Transfer risk / caveat: the review concerns clinical pathology, diagnostic devices, and laboratory validation, not a companion-animal management system; only data-quality and professional-oversight mechanisms transfer to Feature 2.

### Task 3 — Extraction Bank (1–4 rows max, min 1. Never pad.)
| # | Slot | Finding (mechanism + noun) | Condition (n, setting, baseline) | Quote ≤60w + Locator | Metric or [NOT STATED] | Use in TARGET |
|---|---|---|---|---|---|---|
| 1 | Research Context-Macro-Digital-Transformation | EHR and whole-slide-image proliferation creates a data foundation for veterinary AI, but only if digital records are complete and standardized | US veterinary clinical-pathology review; no review-level n | “This potential continues to expand as veterinary clinical pathology is digitalized and electronic health records (EHRs) and whole-slide images (WSIs) proliferate, creating large, high-quality data sets—the foundation for the development of AI-based tools” (Neal et al. 2025, Introduction) | [NOT STATED: EHR coverage, data volume, or completeness rate] | [FOUNDATION] CarePaws will treat the digital health record as the evidentiary base for its AI-assisted summary, requiring consistent clinical fields before any summary is presented to the veterinarian [Feature 2] |
| 2 | Research Context-Micro-Clinical-Breaking-Points | Incomplete records and clerical mistakes create missing values that can distort downstream interpretation | Veterinary clinical-pathology data-preparation context; no review-level n | “Missing values are also frequently encountered even in highly curated data sets due to numerous reasons including but not limited to variability in reporting practices across institutions, sample availability, and incomplete records or clerical mistakes” (Neal et al. 2025, Supervised Model Development) | [NOT STATED: missing-value rate or error contribution] | [DATA-QUALITY] CarePaws will expose incomplete or inconsistent clinical fields in the longitudinal record so the attending veterinarian can judge the AI-assisted summary rather than treating generated text as complete evidence [Feature 2] |
| 3 | Research Context-Micro-Clinical-Breaking-Points | Generative-AI hallucination can produce fictitious or confidently incorrect clinical information | Veterinary clinical-pathology review; no review-level n | “For example, an LLM tasked with the generation of cytopathology reports may confidently diagnose an entirely fictitious entity or, perhaps more concerning, confidently misdiagnose the sample with a real but incorrect entity” (Neal et al. 2025, Neural Networks) | [NOT STATED: hallucination or misdiagnosis rate] | [SAFETY] CarePaws will constrain the AI-assisted summary to the patient record, label it as assistive, and preserve the veterinarian’s sole authority to diagnose, prescribe, or alter the record [Feature 2] |
| 4 | Research Context-Micro-Clinical-Breaking-Points | Model drift and narrow training coverage degrade performance and miss rare or novel diseases | Deployed veterinary clinical-pathology AI context; no review-level n | “Further, current AI models can also only identify what they are trained to identify, meaning rare or novel diseases will be missed” (Neal et al. 2025, Conclusions) | [NOT STATED: drift rate, monitoring interval, or rare-disease sensitivity] | [MONITORING] CarePaws will monitor summary quality against clinician review and record corrections, while requiring the veterinarian to verify novel findings outside the model’s demonstrated scope [Feature 2] |
Excluded: [9] candidates omitted (algorithm definitions, POC instrument features, diagnostic performance tables, FDA device pathways, research-only metrics, sample-prioritization optimization, histopathology pipelines, species-specific studies, and future imaging models).